Furthermore, this is the first study showing that lycopene treatment at low doses can upregulate pulmonary Cx43, which may provide new insights into the mechanism of lycopene action at the molecular level for chemoprevention of lung cancer. This evidence concerns the gene GJA1 and lung carcinoma.